Python & SQL fundamentals
Data manipulation, algorithms, and statistical programming form the coding foundation for most data science interviews.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Data science interviews blend coding, statistics, ML theory, and business impact — requiring both technical depth and communication skills.. Explore key insights and preparation tips to help you excel in your interview process.
Data manipulation, algorithms, and statistical programming form the coding foundation for most data science interviews.
Design end-to-end ML pipelines, feature stores, and recommendation systems at scale.
ML Pipeline
Training & inference workflows
Feature Engineering
Data processing at scale
Model Deployment
Serving & monitoring systems
Different companies emphasize different aspects of data science based on their business needs and scale.
Meta
A/B testing and causal inference for product metrics
Netflix
Recommendation algorithms and personalization at scale
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers 65% lower housing costs than San Francisco while maintaining strong data science salaries in biotech and healthcare. Your $120K salary stretches like $200K+ in the Bay Area, with waterfront condos and historic neighborhoods at a fraction of SF prices.
Baltimore's data science market is significantly less crowded than major tech hubs. Strong demand from Johns Hopkins, federal agencies, and growing biotech sector creates favorable hiring conditions.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States